Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.
NCT01450358 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2016-06-09
Summary
The objective of this study is to evaluate the consumption of antimicrobial therapy in patients comparing a rapid molecular test (PCR in Real-Time Multiplex) with blood cultures to identify the etiological agents of sepsis.
Conditions
- Sepsis
- Bacteremia
- Fungemia
Interventions
- OTHER
-
Antibiotic regimen
The medical researcher will change the antibiotic regimen (De-escalation) immediately as a result of Multiplex PCR (6-12 h).
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
collaborator OTHER_GOV -
Instituto do Coracao
lead OTHER_GOV
Principal Investigators
-
Tania MV Strabelli, PhD · Instituto do Coracao
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- Brazil
Study Locations
More Related Trials
-
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
NCT06491966 ·Status: RECRUITING
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis
NCT00629382 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal and Gut Microbiota Combined Clinical Events Predicts the Prognosis of Septic Patients
NCT05143736 ·Status: RECRUITING
-
Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19
NCT04352985 ·Status: NO_LONGER_AVAILABLE
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 ·Status: WITHDRAWN
-
A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis
NCT03333304 ·Status: COMPLETED ·Phase: NA
-
CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
NCT04049565 ·Status: COMPLETED
-
Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 ·Status: RECRUITING
-
Statin for Immunomudulation in Sepsis
NCT00452608 ·Status: UNKNOWN ·Phase: PHASE2
-
NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification
NCT06141395 ·Status: COMPLETED
-
Adaptive Blood Purification for the Treatment of Patients With Septic Shock
NCT06692036 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic Patients
NCT01862185 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian Hospitals
NCT05267483 ·Status: UNKNOWN
-
Duration of Antibiotic Therapy in Critically Ill Patients: C-reactive Protein-guided Therapy Versus Best Practice
NCT02987790 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
Improving Morbidity During Post-Acute Care Transitions for Sepsis
NCT03865602 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients
NCT00930085 ·Status: COMPLETED ·Phase: NA
-
Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic Approach
NCT01693952 ·Status: UNKNOWN ·Phase: NA
-
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
NCT02519699 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
NCT06548854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2